{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:16:17Z","timestamp":1792548977576,"version":"4.5.0"},"reference-count":77,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Reg Anesth Pain Med"],"accepted":{"date-parts":[[2024,11,28]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background\/Importance<\/jats:title>\n                    <jats:p>Opioids continue to play a key role in managing acute postoperative pain, but their use contributes to adverse outcomes. Buprenorphine may offer effective analgesia with a superior safety profile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the efficacy and safety of buprenorphine with other opioids for acute postoperative pain management in adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Evidence review<\/jats:title>\n                    <jats:p>MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and Web of Science were searched from inception to February 2024. Randomized controlled trials comparing buprenorphine with other opioids for acute postoperative pain management in adults were included. Of 2421 records identified, 58 studies met inclusion criteria. Two reviewers independently extracted data and assessed risk of bias. Random-effects meta-analysis was performed using Stata\/BE V.18. The primary outcome was pain intensity. Secondary outcomes included rescue analgesia use, duration of analgesia, and adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>\n                      Analysis of 41 comparisons (2587 participants) showed buprenorphine significantly reduced pain intensity compared with all other opioids (Hedges\u2019s g=\u22120.36, 95% CI=\u22120.59\u2009to \u22120.14, p&lt;0.001, 95% prediction interval (PI)=\u22121.70 to 0.97). This effect persisted when compared with full agonist opioid (FAO) alone (standardized mean difference \u22120.34, 95% CI=\u22120.59\u2009to \u22120.10, p&lt;0.001, 95% PI=-1.76\u2009to 1.07). Patients receiving buprenorphine were less likely to require rescue analgesia (OR=0.40, 95% CI=0.26\u2009to 0.63, p&lt;0.001, 95% PI=0.12\u2009to 1.36). Mean duration of analgesia was 8.5 hours (SD 1.84). There were no significant differences in other adverse effects including nausea and respiratory depression. Inconsistency was significant for pain intensity (I\n                      <jats:sup>2<\/jats:sup>\n                      =86.28%, 95% CI=81.55%\u2009to 88.99%) and moderate for rescue analgesia (I\n                      <jats:sup>2<\/jats:sup>\n                      =38.93%, 95% CI=1.44%\u2009to 64.37%). Risk of bias was low in 19 studies, with some concerns in 37 studies, and high in two studies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Buprenorphine demonstrated superior efficacy in managing acute postoperative pain compared with FAOs, with a favorable safety profile and longer duration of action. These findings support the use of buprenorphine as a first-line opioid analgesic for acute postoperative pain management requiring opioid analgesia, potentially reducing opioid-related harm in the postoperative period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42023447715.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rapm-2024-106014","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:50:28Z","timestamp":1735869028000},"page":"1-16","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Buprenorphine versus full agonist opioids for acute postoperative pain management: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1136","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4890-0238","authenticated-orcid":false,"given":"Thomas R","family":"Hickey","sequence":"first","affiliation":[{"name":"Anesthesiology, Yale School of Medicine, New Haven, Connecticut, USA"},{"name":"Anesthesiology, VA Connecticut Healthcare System, West Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel P A","family":"Costa","sequence":"additional","affiliation":[{"name":"Universidade de Ribeir\u00e3o Preto, Ribeirao Preto, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Behavioral Health, Saint Elizabeth Hospital DC, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Podosek","sequence":"additional","affiliation":[{"name":"Pharmacy, VA Connecticut Healthcare System, West Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Abelleira","sequence":"additional","affiliation":[{"name":"Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5699-9819","authenticated-orcid":false,"given":"Victor Javier","family":"Avila-Quintero","sequence":"additional","affiliation":[{"name":"Child Study Center, Yale University School of Medicine, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7357-8215","authenticated-orcid":false,"given":"Joao P","family":"De Aquino","sequence":"additional","affiliation":[{"name":"Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA"},{"name":"Psychiatry, VA Connecticut Healthcare System, West Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"2026010506000679000_51.1.1.1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S144066"},{"key":"2026010506000679000_51.1.1.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68700-X"},{"key":"2026010506000679000_51.1.1.3","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.athoracsur.2023.02.013","article-title":"Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection","volume":"116","author":"Zhou","year":"2023","journal-title":"Ann Thorac Surg"},{"key":"2026010506000679000_51.1.1.4","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6610a1"},{"key":"2026010506000679000_51.1.1.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30430-1"},{"key":"2026010506000679000_51.1.1.6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025091","article-title":"Preoperative predictors of poor acute postoperative pain control: a systematic review and meta-analysis","volume":"9","author":"Yang","year":"2019","journal-title":"BMJ Open"},{"key":"2026010506000679000_51.1.1.7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/ajad.13022","article-title":"Incidence of Postoperative Opioid Overdose and New Diagnosis of Opioid Use Disorder Among US Veterans","volume":"29","author":"Siglin","year":"2020","journal-title":"Am J Addict"},{"key":"2026010506000679000_51.1.1.8","first-page":"7","article-title":"In pursuit of the Holy Grail. Nathan B Eddy Award Address","volume":"179","author":"Lewis","year":"1999","journal-title":"NIDA Res Monogr"},{"key":"2026010506000679000_51.1.1.9","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12196"},{"key":"2026010506000679000_51.1.1.10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.5055\/jom.0901","article-title":"Buprenorphine: an anesthesia-centric review","volume":"20","author":"Hickey","year":"2024","journal-title":"J Opioid Mgmt"},{"key":"2026010506000679000_51.1.1.11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bja.2017.11.086","article-title":"Efficacy and adverse effects of buprenorphine in acute pain management: systematic review and meta-analysis of randomised controlled trials","volume":"120","author":"White","year":"2018","journal-title":"Br J Anaesth"},{"key":"2026010506000679000_51.1.1.12","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1007\/s11606-020-06115-3","article-title":"Treating Perioperative and Acute Pain in Patients on Buprenorphine: Narrative Literature Review and Practice Recommendations","volume":"35","author":"Buresh","year":"2020","journal-title":"J Gen Intern Med"},{"key":"2026010506000679000_51.1.1.13","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2021-103007"},{"key":"2026010506000679000_51.1.1.14","doi-asserted-by":"crossref","first-page":"E163","DOI":"10.36076\/ppj.2020\/23\/E163","article-title":"Continuation of Buprenorphine to Facilitate Postoperative Pain Management for Patients on Buprenorphine Opioid Agonist Therapy","volume":"23","author":"Mehta","year":"2020","journal-title":"Pain Physician"},{"key":"2026010506000679000_51.1.1.15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/add.14114","article-title":"Excess overdose mortality immediately following transfer of patients and their care as well as after cessation of opioid substitution therapy","volume":"113","author":"Bogdanowicz","year":"2018","journal-title":"Addiction"},{"key":"2026010506000679000_51.1.1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.03.018"},{"key":"2026010506000679000_51.1.1.17","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-109393"},{"key":"2026010506000679000_51.1.1.18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300251"},{"key":"2026010506000679000_51.1.1.19","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.jpain.2023.07.001","article-title":"Efficacy and Safety of Transdermal Buprenorphine for Acute Postoperative Pain: A Systematic Review and Meta-analysis","volume":"24","author":"Aguilar","year":"2023","journal-title":"J Pain"},{"key":"2026010506000679000_51.1.1.20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/sja.sja_822_22","article-title":"Buprenorphine for acute post-surgical pain: A systematic review and meta-analysis","volume":"17","author":"Albaqami","year":"2023","journal-title":"Saudi J Anaesth"},{"key":"2026010506000679000_51.1.1.21","article-title":"Buprenorphine versus Morphine in Paediatric Acute Pain: A Systematic Review and Meta-Analysis","volume":"2018","author":"Murray","year":"2018","journal-title":"Crit Care Res Pract"},{"key":"2026010506000679000_51.1.1.22","unstructured":"Buxton IO , Benet LZ . Pharmacokinetics: the dynamics of drug absorption, distribution, metabolism, and elimination. In: Brunton L , Chabner BA , Knollmann BC , eds. Goodman & Gilman\u2019s: the pharmacological basis of therapeutics. 14th edn. McGraw-Hill Education, 2023."},{"key":"2026010506000679000_51.1.1.23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s40122-022-00380-2","article-title":"Pharmacokinetics of Buprenorphine Buccal Film and Orally-administered Oxycodone in a Respiratory Study: An Analysis of Secondary Outcomes from a Randomized Controlled Trial","volume":"11","author":"Webster","year":"2022","journal-title":"Pain Ther"},{"key":"2026010506000679000_51.1.1.24","unstructured":"Reckitt Benckiser Healthcare (UK) Ltd . Buprenex [package insert]. 2019."},{"key":"2026010506000679000_51.1.1.25","first-page":"315S","article-title":"A trial of sublingual buprenorphine in cancer pain","volume":"7 Suppl 3","author":"Robbie","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"2026010506000679000_51.1.1.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00188-1"},{"key":"2026010506000679000_51.1.1.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"2026010506000679000_51.1.1.28","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2023-104801"},{"key":"2026010506000679000_51.1.1.29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1213\/ANE.0000000000006607","article-title":"Systematic Reviews and Meta-analyses in Regional Anesthesia and Pain Medicine (Part II): Guidelines for Performing the Systematic Review","volume":"138","author":"D\u2019Souza","year":"2024","journal-title":"Anesth Analg"},{"key":"2026010506000679000_51.1.1.30","unstructured":"Chapter 6: choosing effect measures and computing estimates of effect. Cochraneorg, 2023."},{"key":"2026010506000679000_51.1.1.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2016.01.002"},{"key":"2026010506000679000_51.1.1.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.06.006"},{"key":"2026010506000679000_51.1.1.33","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026010506000679000_51.1.1.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.08.015"},{"key":"2026010506000679000_51.1.1.35","unstructured":"Borenstein M . Common mistakes in meta-analysis and how to avoid them. Biostat. Inc, 2019."},{"key":"2026010506000679000_51.1.1.36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1164","article-title":"Methods to estimate the between-study variance and its uncertainty in meta-analysis","volume":"7","author":"Veroniki","year":"2016","journal-title":"Res Synth Methods"},{"key":"2026010506000679000_51.1.1.37","unstructured":"Chapter 10: analysing data and undertaking meta-analyses. Cochraneorg, 2023."},{"key":"2026010506000679000_51.1.1.38","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117645"},{"key":"2026010506000679000_51.1.1.39","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.309.6965.1351"},{"key":"2026010506000679000_51.1.1.40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"2026010506000679000_51.1.1.41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/009127009703700106","article-title":"Bioavailability of Sublingual Buprenorphine","volume":"37","author":"Mendelson","year":"1997","journal-title":"J Clin Pharma"},{"key":"2026010506000679000_51.1.1.42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF03189469","article-title":"Plasma concentration and disposition of buprenorphine after intravenous and intramuscular doses to baboons","volume":"5","author":"Lloyd-Jones","year":"1980","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"2026010506000679000_51.1.1.43","unstructured":"Levin R . Clinical review - buTrans. FDA; 2010. Available: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2010\/021306Orig1s000MedicalR.pdf"},{"key":"2026010506000679000_51.1.1.44","doi-asserted-by":"publisher","DOI":"10.1002\/cpt197824152"},{"key":"2026010506000679000_51.1.1.45","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3945"},{"key":"2026010506000679000_51.1.1.46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"2026010506000679000_51.1.1.47","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2001.01502.x"},{"key":"2026010506000679000_51.1.1.48","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/82.1.3"},{"key":"2026010506000679000_51.1.1.49","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.21037\/apm.2017.03.01","article-title":"Challenging equipotency calculation for hydromorphone after long-term intravenous application","volume":"6","author":"Luchting","year":"2017","journal-title":"Ann Palliat Med"},{"key":"2026010506000679000_51.1.1.50","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/55.4.319"},{"key":"2026010506000679000_51.1.1.51","unstructured":"Talwin. Package insert. Sanofi-Aventis Pharmaceuticals Inc; 2011."},{"key":"2026010506000679000_51.1.1.52","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/clpt.1985.92","article-title":"Intramuscular meptazinol and morphine in postoperative pain","volume":"37","author":"Kaiko","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"2026010506000679000_51.1.1.53","unstructured":"Shastri DPI . RCT to compare analgesia property of USG-guided fascia iliaca block, IV fentanyl & sublingual tablet buprenorphine for positioning and postoperatively in fracture femur surgery under spinal anesthesia. IARS and SOCCA; 2022"},{"key":"2026010506000679000_51.1.1.54","doi-asserted-by":"crossref","first-page":"567","DOI":"10.5055\/jom.2022.0751","article-title":"Equianalgesic potency ratios of opioids used in patient-controlled analgesia: A network meta-analysis","volume":"18","author":"Dinges","year":"2022","journal-title":"J Opioid Manag"},{"key":"2026010506000679000_51.1.1.55","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aew466"},{"key":"2026010506000679000_51.1.1.56","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2044.1980.tb05125.x","article-title":"Buprenorphine in postoperative pain: results in 7500 patients","volume":"35","author":"Harcus","year":"1980","journal-title":"Anaesthesia"},{"key":"2026010506000679000_51.1.1.57","doi-asserted-by":"publisher","DOI":"10.1021\/jm960073m"},{"key":"2026010506000679000_51.1.1.58","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.094276"},{"key":"2026010506000679000_51.1.1.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2022.05.032"},{"key":"2026010506000679000_51.1.1.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2010.12.007"},{"key":"2026010506000679000_51.1.1.61","doi-asserted-by":"crossref","DOI":"10.3390\/biom11060816","article-title":"Buprenorphine: Far Beyond the \u201cCeiling\u201d","volume":"11","author":"Infantino","year":"2021","journal-title":"Biomolecules"},{"key":"2026010506000679000_51.1.1.62","doi-asserted-by":"publisher","DOI":"10.1124\/mol.110.066613"},{"key":"2026010506000679000_51.1.1.63","doi-asserted-by":"crossref","unstructured":"Pedersen MF , Wr\u00f3bel TM , M\u00e4rcher-R\u00f8rsted E , et al . Biased agonism of clinically approved \u03bc-opioid receptor agonists and TRV130 is not controlled by binding and signaling kinetics. Neuropharmacology 2020;166. doi:10.1016\/j.neuropharm.2019.107718","DOI":"10.1016\/j.neuropharm.2019.107718"},{"key":"2026010506000679000_51.1.1.64","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.18"},{"key":"2026010506000679000_51.1.1.65","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/pm\/pnz356","article-title":"Understanding Buprenorphine for Use in Chronic Pain: Expert Opinion","volume":"21","author":"Webster","year":"2020","journal-title":"Pain Med"},{"key":"2026010506000679000_51.1.1.66","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000457"},{"key":"2026010506000679000_51.1.1.67","unstructured":"Products - vital statistics rapid release - provisional drug overdose data. 2024."},{"key":"2026010506000679000_51.1.1.68","doi-asserted-by":"crossref","first-page":"103545","DOI":"10.1016\/j.drugpo.2021.103545","article-title":"Availability and use of non-prescribed buprenorphine-naloxone in a Canadian setting, 2014-2020","volume":"101","author":"Bach","year":"2022","journal-title":"Int J Drug Policy"},{"key":"2026010506000679000_51.1.1.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.09.007"},{"key":"2026010506000679000_51.1.1.70","doi-asserted-by":"crossref","first-page":"s3","DOI":"10.1191\/0269216306pm1126oa","article-title":"Opioid-induced respiratory effects: new data on buprenorphine","volume":"20 Suppl 1","author":"Dahan","year":"2006","journal-title":"Palliat Med"},{"key":"2026010506000679000_51.1.1.71","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1007\/s12325-020-01481-0","article-title":"A Phase I Placebo-Controlled Trial Comparing the Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Administration on Respiratory Drive","volume":"37","author":"Webster","year":"2020","journal-title":"Adv Ther"},{"key":"2026010506000679000_51.1.1.72","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.71"},{"key":"2026010506000679000_51.1.1.73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256752","article-title":"Effect of sustained high buprenorphine plasma concentrations on fentanyl-induced respiratory depression: A placebo-controlled crossover study in healthy volunteers and opioid-tolerant patients","volume":"17","author":"Moss","year":"2022","journal-title":"PLoS One"},{"key":"2026010506000679000_51.1.1.74","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.bja.2021.11.032","article-title":"Utility of unidimensional and functional pain assessment tools in adult postoperative patients: a systematic review","volume":"128","author":"Baamer","year":"2022","journal-title":"Br J Anaesth"},{"key":"2026010506000679000_51.1.1.75","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/jamasurg.2018.2102","article-title":"Prevalence of Preoperative Opioid Use and Characteristics Associated With Opioid Use Among Patients Presenting for Surgery","volume":"153","author":"Hilliard","year":"2018","journal-title":"JAMA Surg"},{"key":"2026010506000679000_51.1.1.76","doi-asserted-by":"crossref","first-page":"388","DOI":"10.7326\/M22-2917","article-title":"The Use of Opioids in the Management of Chronic Pain: Synopsis of the 2022 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline","volume":"176","author":"Sandbrink","year":"2023","journal-title":"Ann Intern Med"},{"key":"2026010506000679000_51.1.1.77","article-title":"Interventions for preoperative smoking cessation","volume":"2014","author":"Thomsen","year":"2014","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Regional Anesthesia &amp; Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rapm-2024-106014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:01:08Z","timestamp":1767621668000},"score":1,"resource":{"primary":{"URL":"https:\/\/rapm.bmj.com\/lookup\/doi\/10.1136\/rapm-2024-106014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,5]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/rapm-2024-106014"],"URL":"https:\/\/doi.org\/10.1136\/rapm-2024-106014","relation":{},"ISSN":["1098-7339","1532-8651"],"issn-type":[{"value":"1098-7339","type":"print"},{"value":"1532-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]}}}